Artérite de Takayasu et athérosclérose

Hatri, A.; Guermaz, R.; Jp, Laroche; Zekri, S.; Brouri, M.

doi:10.1016/j.jdmv.2019.07.002

Cited by 11 publications

(16 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…8 La inflamación sistémica asociada con la inflamación parietal local observada en la arteritis de Takayasu parece ser la responsable de la aterosclerosis acelerada y prematura. 9 La mortalidad aumentó en comparación con la población general (razón de mortalidad estandarizada, 3.0; IC del 95 %. 1,8,9 La supervivencia global fue del 97 % a los 10 años y del 86 % a los 15 años.…”

Section: Discussionunclassified

“…9 La mortalidad aumentó en comparación con la población general (razón de mortalidad estandarizada, 3.0; IC del 95 %. 1,8,9 La supervivencia global fue del 97 % a los 10 años y del 86 % a los 15 años. 6 Los criterios de clasificación del American College of Rheumatology se desarrollaron para ayudar a distinguir una forma de vasculitis de otra; 12 la paciente tenía cuatro de los seis criterios que deben de estar presentes para hacer el diagnóstico.…”

Section: Discussionunclassified

See 1 more Smart Citation

Arteritis de takayasu presentación de una caso clínico y revisión de la literatura

Solano

Montiel

2022

LUXMED

View full text Add to dashboard Cite

La arteritis de Takayasu es una vasculitis primaria que afecta principalmente a la aorta y sus vasos principales, las arterias pulmonares y las arterias coronarias, en mujeres jóvenes. También comparte algunas características histológicas y clínicas con la arteritis de células gigantes (temporal), la otra vasculitis importante de grandes vasos. El involucro cardiaco es debido a lesiones vasculares, así como por patología primaria del corazón. Dentro de la sintomatología de los pacientes, se pueden presentar síntomas inflamatorios sistemáticos no específicos, así como síntomas relacionados con las lesiones vasculares estenóticas, que pueden ir desde pérdida de la agudeza visual, infarto agudo del miocardio, insuficiencia cardiaca, trombosis cerebral e hipertensión maligna.

show abstract

Section: Discussionunclassified

Arteritis de takayasu presentación de una caso clínico y revisión de la literatura

Solano

Montiel

2022

LUXMED

View full text Add to dashboard Cite

show abstract

“…Definitive proof of accelerated atherosclerosis has also been documented in these patients [30,31,34]. When carotid ultrasound was performed in 30 TAK patients (average age 35 years) and age-and sex-matched patients with SLE and healthy controls, atherosclerotic plaque was visualized in 27% of TAK patients, as compared to 18% of SLE and only 2% of healthy controls (p = 0.005) [31].…”

Section: Surrogate Markers and Accelerated Atherosclerosis In Takmentioning

confidence: 97%

“…1). With respect to surrogate markers of atherosclerosis, increased carotid intima-media thickness (cIMT) has been observed in TAK patients, as compared to age-matched controls and those with SLE [30,31]. In addition, brachial-ankle pulse wave velocity (baPWV), a marker of arterial stiffness, is significantly elevated in TAK and correlates independently with disease activity [32].…”

Section: Surrogate Markers and Accelerated Atherosclerosis In Takmentioning

confidence: 99%

“…Autopsy evaluation has demonstrated the concomitant presence of both atherosclerosis and vasculitis in young patients [34]. The increased presence of plaques correlates with age [31] but not with traditional CV risk factors or Framingham risk calculations [30]. While studies show increased frequencies of metabolic syndrome [35], hypertension [26,35,36], and hypertriglyceridemia [35], this is most likely not a major source of risk for TAK patients and likely does not account for the increased CV events observed [30,31,33].…”

Section: Surrogate Markers and Accelerated Atherosclerosis In Takmentioning

confidence: 99%

See 1 more Smart Citation

Cardiovascular events and the role of accelerated atherosclerosis in systemic vasculitis

Clifford

Tervaert

2021

Atherosclerosis

View full text Add to dashboard Cite

The spectrum of inflammatory blood vessel diseases includes both atherosclerosis and the primary systemic vasculitides. Although the inciting triggers differ, significant overlap exists in the mechanisms that contribute to sustained inflammation and vascular damage in both entities. With improvement in therapeutics to control acute vasculitis leading to longer survival, cardiovascular morbidity and mortality has emerged as the leading cause of death for vasculitis patients. Cardiovascular events likely occur as a consequence of vasculitis, vascular damage from prior inflammation causing a sustained procoagulant state, and accelerated atherosclerosis. In this review, we discuss the latest evidence regarding risk of cardiovascular events in patients with major forms of primary systemic vasculitis, and review the mechanisms by which accelerated atherosclerosis may occur.

show abstract

Clinical features and risk factors of intracranial artery disease in patients with Takayasu arteritis

Guo

et al. 2022

Clin Rheumatol

View full text Add to dashboard Cite

Artérite de Takayasu et athérosclérose

Cited by 11 publications

References 22 publications

Arteritis de takayasu presentación de una caso clínico y revisión de la literatura

Arteritis de takayasu presentación de una caso clínico y revisión de la literatura

Cardiovascular events and the role of accelerated atherosclerosis in systemic vasculitis

Clinical features and risk factors of intracranial artery disease in patients with Takayasu arteritis

Contact Info

Product

Resources

About